microRNA-27b inhibits cell proliferation and invasion in bladder cancer by targeting engrailed-2

Yunfei Li1, Qilin Duan1, Lu Gan1

  • 1Department of Urology, Third Affilated Hospital of Shenzhen University, Shenzhen 518000, China.

Bioscience Reports
|December 22, 2020
PubMed
Abstract

Insights

MicroRNA-27b downregulates engrailed-2, inhibiting bladder cancer progression. This microRNA-27b/engrailed-2 pathway impacts bladder cancer development and offers potential therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Bladder cancer is a heterogeneous malignancy.
  • Engrailed-2 (EN2) is a potential gene involved in bladder cancer.
  • Bioinformatics revealed a complementarity between microRNA-27b (miR-27b) and EN2.

Purpose of the Study:

  • To investigate the reciprocal association between miR-27b and EN2 in bladder cancer.
  • To elucidate the role of the miR-27b/EN2 axis in bladder cancer pathogenesis.

Main Methods:

  • Quantification of miR-27b and EN2 protein in bladder tissues and cells.
  • Assessment of tumor cell apoptosis, proliferation, invasion, and migration.
  • Luciferase reporter assays to confirm the interaction between miR-27b and EN2.
  • In vitro and in vivo validation of the miR-27b/EN2 interaction.

Main Results:

  • miR-27b expression was downregulated, while EN2 expression was upregulated in bladder cancer tissues and cells.
  • miR-27b negatively regulated EN2 expression.
  • miR-27b transfection reduced bladder cancer cell activity and promoted apoptosis.
  • EN2 restoration reversed the effects of miR-27b in vitro and in vivo.
  • miR-27b expression correlated significantly with bladder cancer clinicopathological grade.

Conclusions:

  • EN2 is implicated in bladder cancer development via negative mediation by miR-27b.
  • The miR-27b/EN2 signaling pathway significantly influences bladder cancer progression.
  • Targeting the miR-27b/EN2 axis may offer therapeutic strategies for bladder cancer.